• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Micel Corporation

Micel Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. GenSight Biologics to Present Data on GS010 and GS030 at the 2017 Congress of the European Society of Gene & Cell Therapy

    GenSight Biologics to Present Data on GS010 and GS030 at the 2017 Congress of the European Society of Gene & Cell Therapy

  2. ABIVAX Presents Novel Data on the Efficacy of Its Immune Enhancer ABX196 in Animal Model of Liver Cancer at the World Vaccine Congress

    ABIVAX Presents Novel Data on the Efficacy of Its Immune Enhancer ABX196 in Animal Model of Liver Cancer at the World Vaccine Congress

  3. Ligand to Acquire Crystal Bioscience, the Leader in Chicken-derived Fully-human Antibody Generation, for $25 Million in Cash plus Additional Potential Payments

    Ligand to Acquire Crystal Bioscience, the Leader in Chicken-derived Fully-human Antibody Generation, for $25 Million in Cash plus Additional Potential Payments

  4. Catabasis Pharmaceuticals to Present Results from Joint Research Collaboration with Sarepta Therapeutics at the 22nd International Congress of the World Muscle Society

    Catabasis Pharmaceuticals to Present Results from Joint Research Collaboration with Sarepta Therapeutics at the 22nd International Congress of the World Muscle Society

  5. Therapix Biosciences shares surge 6% on preclinical results for cognitive impairment therapy

    Therapix Biosciences shares surge 6% on preclinical results for cognitive impairment therapy

  6. Contagion® Launches First Peer Exchange on Lyme Disease

    ContagionĀ® Launches First Peer Exchange on Lyme Disease

12345

©2017 Morningstar Advisor. All right reserved.